Cow's milk allergy as a predictor of bronchial hyperresponsiveness and airway inflammation at school age

L P Malmberg1, K M Saarinen, A S Pelkonen

  • 1Department of Allergy, Skin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland. pekka.malmberg@hus.fi

Insights

Children with a history of IgE-positive cow's milk allergy (CMA) show increased airway inflammation and bronchial hyperresponsiveness (BHR) at school age. IgE-negative CMA did not show these associations, but early cow's milk exposure was linked to less BHR.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Immunology

Background:

  • Cow's milk allergy (CMA) is linked to childhood asthma, but prospective data on airway inflammation and bronchial hyperresponsiveness (BHR) are limited.
  • Understanding the long-term respiratory effects of CMA is crucial for early intervention.

Purpose of the Study:

  • To investigate cow's milk allergy (CMA) as a risk factor for childhood airway inflammation and bronchial hyperresponsiveness (BHR).

Main Methods:

  • Prospective follow-up of 118 children with CMA, with clinical visits at a mean age of 8.6 years.
  • Measurements included exhaled nitric oxide (FeNO) and histamine bronchial challenge.
  • Comparison with 80 control subjects from the same cohort.

Main Results:

  • Children with a history of CMA exhibited higher FeNO levels and increased bronchial responsiveness to histamine compared to controls.
  • IgE-positive CMA was significantly associated with increased FeNO and BHR, independent of early wheeze and parental smoking.
  • IgE-negative CMA showed no association with FeNO or BHR; early cow's milk exposure correlated with reduced BHR.

Conclusions:

  • IgE-positive cow's milk allergy (CMA) is a significant predictor of airway inflammation and bronchial hyperresponsiveness (BHR) in school-aged children.
  • IgE-negative CMA does not appear to confer the same respiratory risks.
  • Early cow's milk exposure may have a protective effect against BHR.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: